ElevateBio racks up $150 mln Series A
Cambridge, Massachusetts-based ElevateBio, a biotech holding company, has secured $150 million in Series A financing. The investors included UBS Oncology Impact Fund, EcoR1 Capital, Redmile Group and Samsara BioCapital.
13 May 2019•1 min read
